November 18, 2015
Vertex gets EU approval for expanded use of its cystic fibrosis drug Kalydeco
The European Commission has approved expansion of the indication for Vertex Pharmaceuticals’ Kalydeco, to include children ages 2-5 with cystic fibrosis…